|1.||Lirussi, Frédéric: 1 article (07/2006)|
|2.||Pussard, Eric: 1 article (07/2006)|
|3.||Stepniewska, K: 1 article (11/2003)|
|4.||Jantra, A: 1 article (11/2003)|
|5.||Huyakorn, S: 1 article (11/2003)|
|6.||Looareesuwan, S: 1 article (11/2003)|
|7.||White, N J: 1 article (11/2003)|
|8.||Pukrittayakamee, S: 1 article (11/2003)|
|9.||Wanwimolruk, S: 1 article (11/2003)|
01/01/1997 - "The mean ratio of quinine to 3-hydroxyquinine area under the plasma concentration-time curve (AUC) values in acute malaria was 12.03 compared with 6.92 during convalescence P = 0.01. "
01/01/1997 - "During acute malaria infection, the systemic clearance of quinine, antipyrine and ICG and the biotransformation of quinine to 3-hydroxyquinine were all reduced significantly when compared with values during convalescence. "
05/01/1989 - "The formation rate constant and elimination rate constant for 3-hydroxyquinidine were determined in eight patients with ventricular tachycardia. "
05/01/1989 - "Disposition of 3-hydroxyquinidine in patients receiving initial intravenous quinidine gluconate for electrophysiology testing of ventricular tachycardia."
10/01/1987 - "Quinidine and 3-hydroxyquinidine prevented ventricular fibrillation and ventricular tachycardia after coronary reperfusion in a concentration-dependent manner. "
|5.||Acute Kidney Injury (Acute Renal Failure)
01/01/1999 - "The plasma concentrations of quinine and its main metabolite, 3-hydroxyquinine (3OHQn), were measured in 5 adult Thai patients with severe Plasmodium falciparum malaria and acute renal failure. "
01/01/1999 - "Pharmacokinetics of quinine and 3-hydroxyquinine in severe falciparum malaria with acute renal failure."
|5.||quinidine gluconate (Quinact)